Cargando…
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer
In cancer patients, hypercoagulability is a common finding. It has been associated with an increased risk of venous thromboembolism, but also to tumor proliferation and progression. In this prospective study of a large cohort of breast cancer patients, we aimed to evaluate whether pre-chemotherapy a...
Autores principales: | Giaccherini, Cinzia, Marchetti, Marina, Masci, Giovanna, Verzeroli, Cristina, Russo, Laura, Celio, Luigi, Sarmiento, Roberta, Gamba, Sara, Tartari, Carmen J., Diani, Erika, Vignoli, Alfonso, Malighetti, Paolo, Spinelli, Daniele, Tondini, Carlo, Barni, Sandro, Giuliani, Francesco, Petrelli, Fausto, D’Alessio, Andrea, Gasparini, Giampietro, De Braud, Filippo, Santoro, Armando, Labianca, Roberto, Falanga, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271573/ https://www.ncbi.nlm.nih.gov/pubmed/31558668 http://dx.doi.org/10.3324/haematol.2019.228981 |
Ejemplares similares
-
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer
por: Giaccherini, Cinzia, et al.
Publicado: (2022) -
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence
por: Gomez-Rosas, Patricia, et al.
Publicado: (2021) -
S306: HYPERCOAGULABILITY BIOMARKERS AND THROMBIN GENERATION (TG) PREDICT VENOUS THROMBOEMBOLISM (VTE) IN METASTATIC LUNG CANCER PATIENTS
por: Gomez Rosas, Patricia, et al.
Publicado: (2023) -
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients
por: Gomez-Rosas, Patricia, et al.
Publicado: (2023) -
Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination
por: Schieppati, Francesca, et al.
Publicado: (2021)